Company / Operating Income per Share
Cue Biopharma, Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.43
FY2025
5-year range
-$1.65 / -$0.43
FY2021-FY2025
Trend
+51.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has increased for 3 consecutive years, from $-1.65 in FY2022 to $-0.43 in FY2025.
Based on SEC 10-K filings.
-0.43 in FY2025.
Improved from $-1.10 to $-0.43 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Cue Biopharma, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 51.1% year-over-year.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.43 | +51.1% |
| FY2024 | -$0.88 | +20.4% |
| FY2023 | -$1.10 | +33.2% |
| FY2022 | -$1.65 | -14.8% |
| FY2021 | -$1.44 | -4.0% |
| FY2020 | -$1.38 | +26.0% |
| FY2019 | -$1.87 | -56.6% |
| FY2018 | -$1.19 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026